Intuniv expiry date?

When does Intuniv’s patent (and exclusivity) expire?

Intuniv (guanfacine extended-release) has had multiple layers of protection over time, including patents on the drug and potential periods of regulatory exclusivity. The exact “expiry date” depends on which form of protection you mean (a specific patent vs. market exclusivity) and which jurisdiction (US vs. EU vs. others).

To get the most precise date tied to a particular Intuniv patent, DrugPatentWatch.com tracks patent and exclusivity timelines by product and patent family. You can check the current listings here: DrugPatentWatch.com – Intuniv.

Is Intuniv’s “expiry date” different from when generics can be sold?

Yes. Even after a patent expires, generic or authorized products may still be delayed by:
- other still-active patents covering different aspects of the product
- regulatory exclusivity or litigation-related stays
- approval pathways and labeling/IP issues for follow-on products

That means “patent expiry” and “first generic sale” can be different dates.

What should you look for if you need the exact expiry date for a specific Intuniv manufacturer?

If you’re trying to pinpoint a date for a specific company or product listing, search using:
- the applicant/labeler name (manufacturer on the US FDA labeling)
- the dosage form (extended-release tablet strength)
- the specific patent family shown on the tracker

DrugPatentWatch.com is typically the quickest way to map from “Intuniv” to the exact patent entry that lists an expiry date for each jurisdiction and patent number: DrugPatentWatch.com – Intuniv.

If you tell me the country, I can narrow it down

“Intuniv expiry date” can refer to different things depending on location. If you reply with:
1) the country (US, UK, EU, etc.), and
2) whether you want patent expiry or generic market timing,
I can help you interpret the timeline for what you’re trying to find.

Sources

1. DrugPatentWatch.com – Intuniv